Supernus Pharmaceuticals | Capital Social E Reservas





Capital Social e Reservas Alterar Data
Abbott USD 50.83B 0 2025-09
ANI Pharmaceuticals USD 505.82M 69.06M 2025-09
Aurora Cannabis CAD 567.1M 21.58M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 736.01M 247.04M 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Corcept Therapeutics USD 631.9M 3.89M 2025-09
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 23.79B 5.52B 2025-09
Novo Nordisk DKK 194.05B 24.15B 2025-12
Pacira USD 727.21M 30.55M 2025-09
Perrigo USD 4.45B 25.8M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Supernus Pharmaceuticals USD 1.05B 14.23M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09
Xeris Pharmaceuticals USD -861K 18.44M 2025-09


Supernus Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.